Orphazyme: Follow-up note after sIBM top-line results
Research Note
2021-03-29
13:41
Redeye provides a follow-up note to the top-line results in sporadic Inclusion Body Myositis (sIBM) and after having spoken to the management team.
AH
Anders Hedlund
Disclosures and disclaimers